Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proof-of-Concept Study on the Use of Tangerine-Derived Nanovesicles as siRNA Delivery Vehicles toward Colorectal Cancer Cell Line SW480.
Rabienezhad Ganji N, Urzì O, Tinnirello V, Costanzo E, Polito G, Palumbo Piccionello A, Manno M, Raccosta S, Gallo A, Lo Pinto M, Calligaris M, Scilabra SD, Di Bella MA, Conigliaro A, Fontana S, Raimondo S, Alessandro R. Rabienezhad Ganji N, et al. Among authors: tinnirello v. Int J Mol Sci. 2023 Dec 30;25(1):546. doi: 10.3390/ijms25010546. Int J Mol Sci. 2023. PMID: 38203716 Free PMC article.
Industrial-produced lemon nanovesicles ameliorate experimental colitis-associated damages in rats via the activation of anti-inflammatory and antioxidant responses and microbiota modification.
Tinnirello V, Zizzo MG, Conigliaro A, Tabone M, Ganji NR, Cicio A, Bressa C, Larrosa M, Rappa F, Vergilio G, Gasparro R, Gallo A, Serio RM, Alessandro R, Raimondo S. Tinnirello V, et al. Biomed Pharmacother. 2024 May;174:116514. doi: 10.1016/j.biopha.2024.116514. Epub 2024 Apr 3. Biomed Pharmacother. 2024. PMID: 38574618 Free article.
Protective effects of lemon nanovesicles: evidence of the Nrf2/HO-1 pathway contribution from in vitro hepatocytes and in vivo high-fat diet-fed rats.
Gasparro R, Gambino G, Duca G, Majo DD, Di Liberto V, Tinnirello V, Urone G, Ricciardi N, Frinchi M, Rabienezhad Ganji N, Vergilio G, Zummo FP, Rappa F, Fontana S, Conigliaro A, Sardo P, Ferraro G, Alessandro R, Raimondo S. Gasparro R, et al. Among authors: tinnirello v. Biomed Pharmacother. 2024 Nov;180:117532. doi: 10.1016/j.biopha.2024.117532. Epub 2024 Oct 8. Biomed Pharmacother. 2024. PMID: 39383731 Free article.
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial.
Pracoń R, Spertus JA, Broderick S, Bangalore S, Rockhold FW, Ruzyllo W, Demchenko E, Nageh T, Grossman GB, Mavromatis K, Manjunath CN, Smanio PEP, Stone GW, Mancini GBJ, Boden WE, Newman JD, Reynolds HR, Hochman JS, Maron DJ; ISCHEMIA Research Group. Pracoń R, et al. Circ Cardiovasc Interv. 2024 Jun;17(6):e013435. doi: 10.1161/CIRCINTERVENTIONS.123.013435. Epub 2024 Apr 17. Circ Cardiovasc Interv. 2024. PMID: 38629312 Clinical Trial.
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators. Das Pradhan A, et al. N Engl J Med. 2022 Nov 24;387(21):1923-1934. doi: 10.1056/NEJMoa2210645. Epub 2022 Nov 5. N Engl J Med. 2022. PMID: 36342113 Clinical Trial.
15 results